UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054180
Receipt number R000058661
Scientific Title Efficacy of acupuncture self-care patch for migraine
Date of disclosure of the study information 2024/04/17
Last modified on 2024/04/17 16:05:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of acupuncture self-care patch for migraine

Acronym

Efficacy of acupuncture self-care patch for migraine

Scientific Title

Efficacy of acupuncture self-care patch for migraine

Scientific Title:Acronym

Efficacy of acupuncture self-care patch for migraine

Region

Japan


Condition

Condition

migraine

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine the efficacy of the two patch systems as a self-administered acupuncture treatment for migraine.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

headache days

Key secondary outcomes

Responder rate
Medication days
Headache Impact Test


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

needle patch

Interventions/Control_2

non-needle patch

Interventions/Control_3

control

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

I. Has migraine with or without aura based on the International Classification of Headache Disorders, 3rd edition.
II. 18 years of age or older.
III. Migraine attacks three or more times a month.
IV. Capable of obtaining informed consent in writing.
V. Has not changed or added prophylactic medication for migraines for more than three months.

Key exclusion criteria

The other type of headache
Has a history of severe mental illness, and/or is currently undergoing treatment for a mental disorder.
Pregnant or breastfeeding
Receiving acupuncture treatment elsewhere.
Experiences migraine attacks two or fewer times per month.
Has used calcitonin gene-related peptide antibody drugs in the past three months.
Is currently receiving treatment for malignant tumors.
Has a hemorrhagic disease.
Has a metal allergy.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Sumire
Middle name
Last name ISHIYAMA

Organization

Ibaraki Prefectural University of Health Sciences

Division name

Center of Medical Sciences

Zip code

3000394

Address

4669-2, Ami-machi, Ami, Ibaraki, Japan

TEL

0298884000

Email

ishiyamasu@ipu.ac.jp


Public contact

Name of contact person

1st name Sumire
Middle name
Last name ISHIYAMA

Organization

Ibaraki Prefectural University of Health Sciences

Division name

Center of Medical Sciences

Zip code

3000394

Address

4669-2, Ami-machi, Ami, Ibaraki, Japan

TEL

0298884000

Homepage URL


Email

ishiyamasu@ipu.ac.jp


Sponsor or person

Institute

Ibaraki Prefectural University of Health Sciences

Institute

Department

Personal name



Funding Source

Organization

self-procurement

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ibaraki Prefectural University of Health Sciences

Address

4669-2, Ami-machi, Ami, Ibaraki, Japan

Tel

0298884000

Email

ishiyamasu@ipu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 05 Month 24 Day

Date of IRB

2023 Year 05 Month 24 Day

Anticipated trial start date

2023 Year 08 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 17 Day

Last modified on

2024 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058661


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name